NCT01872819 2018-07-11
Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay
University of Washington
Phase NA Completed
University of Washington
Fred Hutchinson Cancer Center
King Faisal Specialist Hospital & Research Center
National Cancer Institute (NCI)